Telmisartan and Stroke Reduction in the ONTARGET Trial: Benefit beyond Blood Pressure Lowering?

Publisher： Karger

E-ISSN： 1421-9786|26|5|563-564

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.26, Iss.5, 2008-10, pp. : 563-564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Telmisartan: from lowering blood pressure to end-organ protection

By Unger Thomas   Schupp Michael  

Future Cardiology, Vol. 1, Iss. 1, 2005-01 ,pp. : 7-15

Future Medicine

Access to resources Recommend Favorite

Blood Pressure Lowering and Outcomes in type 2 Diabetes: Implications of the Blood Pressure-Lowering Arm of the Advance Trial

By  

Current Hypertension Reviews, Vol. 5, Iss. 3, 2009-01 ,pp. : 168-180

Bentham Science Publishers

Access to resources Recommend Favorite

Early Blood Pressure Reduction in Acute Ischemic Stroke with Various Severities: A Subgroup Analysis of the CATIS Trial

By  

Cerebrovascular Diseases, Vol. 42, Iss. 3-4, 2016-04 ,pp. : 186-195

Karger

Access to resources Recommend Favorite

Blood Pressure and Lipid Lowering in the Prevention of Stroke: A Note to Neurologists

By  

Cerebrovascular Diseases, Vol. 16, Iss. 3, 2003-06 ,pp. : 33-38

Karger

Access to resources Recommend Favorite

Blood Pressure Reduction in the Primary and Secondary Prevention of Stroke

By  

Current Vascular Pharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 155-160

Bentham Science Publishers

Access to resources Recommend Favorite